Needham & Company analyst Mike Matson downgraded NuVasive (NASDAQ: NUVA) from Buy to Hold.The analyst offers 4 reasons for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE